Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6603)
All Articles published online
|
Publishing Process of This Article
|
Jun 14, 2014 (publication date) through Jan 31, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Włodarczyk M, Sobolewska A, Wójcik B, Loga K, Fichna J, Wiśniewska-Jarosińska M. Correlations between skin lesions induced by anti-tumor necrosis factor-α and selected cytokines in Crohn's disease patients. World J Gastroenterol 2014; 20(22): 7019-7026 [PMID: 24944497 DOI: 10.3748/wjg.v20.i22.7019] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i22/7019.htm |
| Number | Citing Articles |
| 1 |
Wenhui Xie, Shiyu Xiao, Hong Huang, Zhuoli Zhang. Incidence of and Risk Factors for Paradoxical Psoriasis or Psoriasiform Lesions in Inflammatory Bowel Disease Patients Receiving Anti-TNF Therapy: Systematic Review With Meta-Analysis. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.847160
|
| 2 |
Iván Guerra, Tamara Pérez-Jeldres, Marisa Iborra, Alicia Algaba, David Monfort, Xavier Calvet, María Chaparro, Miriam Mañosa, Esther Hinojosa, Miguel Minguez, Jone Ortiz de Zarate, Lucía Márquez, Vanessa Prieto, Valle García-Sánchez, Jordi Guardiola, G. Esther Rodriguez, María Dolores Martín-Arranz, Iván García-Tercero, Beatriz Sicilia, Ángeles Masedo, Rufo Lorente, Montserrat Rivero, Luis Fernández-Salazar, Ana Gutiérrez, Manuel Van Domselaar, Antonio López-SanRomán, Yolanda Ber, Marifé García-Sepulcre, Laura Ramos, Fernando Bermejo, Javier P. Gisbert. Incidence, Clinical Characteristics, and Management of Psoriasis Induced by Anti-TNF Therapy in Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2016; 22(4): 894 doi: 10.1097/MIB.0000000000000757
|
| 3 |
Francisco J. Melo, Sofia Magina. Clinical management of Anti‐TNF‐alpha‐induced psoriasis or psoriasiform lesions in inflammatory bowel disease patients: a systematic review. International Journal of Dermatology 2018; 57(12): 1521 doi: 10.1111/ijd.14072
|
| 4 |
Ni Lian, Li Zhang, Min Chen. Tumor necrosis factors‐α inhibition‐induced paradoxical psoriasis: A case series and literature review. Dermatologic Therapy 2020; 33(6) doi: 10.1111/dth.14225
|
| 5 |
Qianqian Zhou, Shengru Zhou, Huizi Xiong, Jianqiu Yang, Ziliang Yang, Naihui Zhou, Jinzhu Mao, Min Li. A Case of Paradoxical Reactions to Biologic Therapy for Psoriasis. Clinical, Cosmetic and Investigational Dermatology 2023; : 1493 doi: 10.2147/CCID.S412520
|
| 6 |
Jason Ya, Jeffery Z. Hu, Amy S. Nowacki, Urmi Khanna, Sean Mazloom, Gowri Kabbur, M. Elaine Husni, Anthony P. Fernandez. Family history of psoriasis, psychological stressors, and tobacco use are associated with the development of tumor necrosis factor-α inhibitor-induced psoriasis: A case-control study. Journal of the American Academy of Dermatology 2020; 83(6): 1599 doi: 10.1016/j.jaad.2020.06.081
|
| 7 |
Yaning Shi, Prithy Rupa, Bo Jiang, Yoshinori Mine. Hydrolysate from Eggshell Membrane Ameliorates Intestinal Inflammation in Mice. International Journal of Molecular Sciences 2014; 15(12): 22728 doi: 10.3390/ijms151222728
|
| 8 |
Siegfried Segaert, Caroline Hermans. Clinical Signs, Pathophysiology and Management of Cutaneous Side Effects of Anti-Tumor Necrosis Factor Agents. American Journal of Clinical Dermatology 2017; 18(6): 771 doi: 10.1007/s40257-017-0296-7
|
| 9 |
Yaning Shi, Jie Zhou, Bo Jiang, Ming Miao. Resveratrol and inflammatory bowel disease. Annals of the New York Academy of Sciences 2017; 1403(1): 38 doi: 10.1111/nyas.13426
|
| 10 |
Alec Eligius Hellström, Martti Färkkilä, Kaija-Leena Kolho. Infliximab-induced skin manifestations in patients with inflammatory bowel disease. Scandinavian Journal of Gastroenterology 2016; 51(5): 563 doi: 10.3109/00365521.2015.1125524
|
| 11 |
Johannan F. Brandse, Laura M. C. Vos, Jeroen Jansen, Toos Schakel, Cyriel I. J. Ponsioen, Gijs R. van den Brink, Geert R. D’Haens, Mark Löwenberg. Serum Concentration of Anti-TNF Antibodies, Adverse Effects and Quality of Life in Patients with Inflammatory Bowel Disease in Remission on Maintenance Treatment. Journal of Crohn's and Colitis 2015; 9(11): 973 doi: 10.1093/ecco-jcc/jjv116
|
| 12 |
Zuzana Jiraskova Zakostelska, Zuzana Reiss, Helena Tlaskalova-Hogenova, Filip Rob. Paradoxical Reactions to Anti-TNFα and Anti-IL-17 Treatment in Psoriasis Patients: Are Skin and/or Gut Microbiota Involved?. Dermatology and Therapy 2023; 13(4): 911 doi: 10.1007/s13555-023-00904-4
|
| 13 |
Ting-Ting Zhang, Junli Ma, Kenneth R. Durbin, Timothy Montavon, Susan E. Lacy, Gary J. Jenkins, Stella Doktor, J. Cory Kalvass. Determination of IL-23 Pharmacokinetics by Highly Sensitive Accelerator Mass Spectrometry and Subsequent Modeling to Project IL-23 Suppression in Psoriasis Patients Treated with Anti-IL-23 Antibodies. The AAPS Journal 2019; 21(5) doi: 10.1208/s12248-019-0352-8
|
| 14 |
Sharon Rose, Shivani B. Kaushik, Mark Lebwohl. Skin Diseases in the Immunosuppressed. 2018; : 155 doi: 10.1007/978-3-319-68790-2_8
|
| 15 |
Sara Campos, Inês Coutinho, José Carlos Cardoso, Francisco Portela. Metastatic Crohn’s disease despite infliximab therapy. Anais Brasileiros de Dermatologia 2017; 92(5 suppl 1): 104 doi: 10.1590/abd1806-4841.20175713
|
| 16 |
Minnie Au, Georgina Heddle, Edward Young, Emma Ryan, Scott Graf, Derrick Tee, Hamish Philpott. Anti‐tumour necrosis factor‐induced skin rashes in inflammatory bowel disease: a systematic review and evidence‐based management algorithm. Internal Medicine Journal 2023; 53(10): 1854 doi: 10.1111/imj.15859
|
| 17 |
Lauren A. George, Akash Gadani, Raymond K. Cross, Guruprasad Jambaulikar, Leyla J. Ghazi. Psoriasiform Skin Lesions Are Caused by Anti-TNF Agents Used for the Treatment of Inflammatory Bowel Disease. Digestive Diseases and Sciences 2015; 60(11): 3424 doi: 10.1007/s10620-015-3763-0
|
| 18 |
Glenn Harvin, George Kasarala. Two Cases of Paradoxical Hidradenitis Suppurativa while on Adalimumab. Case Reports in Gastroenterology 2016; 10(1): 92 doi: 10.1159/000444442
|
| 19 |
Rodrigo Fedatto Beraldo, Mariana Barros Marcondes, Julio Pinheiro Baima, Jaqueline Ribeiro Barros, Madhoor Ramdeen, Rogerio Saad-Hossne, Ligia Yukie Sassaki. <p>Hidradenitis Suppurativa as a Paradoxical Side Effect to the Use of Adalimumab in Patients with Crohn’s Disease?</p>. Clinical and Experimental Gastroenterology 2020; : 293 doi: 10.2147/CEG.S263685
|
| 20 |
Jacqueline Moreau, Erica Bromberg, Laura Korb Ferris. Psoriatic Arthritis and Psoriasis. 2016; : 281 doi: 10.1007/978-3-319-19530-8_28
|
| 21 |
Aleksandra Sobolewska-Włodarczyk, Marcin Włodarczyk. Introduction to Gastrointestinal Diseases Vol. 1. 2017; : 83 doi: 10.1007/978-3-319-49016-8_6
|
| 22 |
T Cabaleiro, R Prieto-Pérez, R Navarro, G Solano, M Román, D Ochoa, F Abad-Santos, E Daudén. Paradoxical psoriasiform reactions to anti-TNFα drugs are associated with genetic polymorphisms in patients with psoriasis. The Pharmacogenomics Journal 2016; 16(4): 336 doi: 10.1038/tpj.2015.53
|
| 23 |
Gabrielle Brown, Eva Wang, Argentina Leon, Monica Huynh, Mackenzie Wehner, Rebecca Matro, Eleni Linos, Wilson Liao, Anna Haemel. Tumor necrosis factor-α inhibitor-induced psoriasis: Systematic review of clinical features, histopathological findings, and management experience. Journal of the American Academy of Dermatology 2017; 76(2): 334 doi: 10.1016/j.jaad.2016.08.012
|
| 24 |
Farzad Alinaghi, Hasan Göcker Tekin, Johan Burisch, Jashin J Wu, Jacob P Thyssen, Alexander Egeberg. Global Prevalence and Bidirectional Association Between Psoriasis and Inflammatory Bowel Disease—A Systematic Review and Meta-analysis. Journal of Crohn's and Colitis 2020; 14(3): 351 doi: 10.1093/ecco-jcc/jjz152
|
| 25 |
J. M. Bae, H. H. Lee, B.‐I. Lee, K.‐M. Lee, S. H. Eun, M.‐L. Cho, J. S. Kim, J. M. Park, Y.‐S. Cho, I. S. Lee, S. W. Kim, H. Choi, M.‐G. Choi. Incidence of psoriasiform diseases secondary to tumour necrosis factor antagonists in patients with inflammatory bowel disease: a nationwide population‐based cohort study. Alimentary Pharmacology & Therapeutics 2018; 48(2): 196 doi: 10.1111/apt.14822
|
| 26 |
Mio Nakamura, Kristina Lee, Rasnik Singh, Tian Hao Zhu, Benjamin Farahnik, Michael Abrouk, John Koo, Tina Bhutani. Eczema as an adverse effect of anti-TNFα therapy in psoriasis and other Th1-mediated diseases: a review. Journal of Dermatological Treatment 2017; 28(3): 237 doi: 10.1080/09546634.2016.1230173
|